Abstract: The present invention relates to novel compounds comprising novel delivery moieties for delivery of oligonucleotides, which are useful in the treatment of disease, suitably diseases of the liver.
| # | Name | Date |
|---|---|---|
| 1 | 202317088040-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [22-12-2023(online)].pdf | 2023-12-22 |
| 2 | 202317088040-STATEMENT OF UNDERTAKING (FORM 3) [22-12-2023(online)].pdf | 2023-12-22 |
| 3 | 202317088040-Sequence Listing in txt [22-12-2023(online)].txt | 2023-12-22 |
| 4 | 202317088040-Sequence Listing in PDF [22-12-2023(online)].pdf | 2023-12-22 |
| 5 | 202317088040-PRIORITY DOCUMENTS [22-12-2023(online)].pdf | 2023-12-22 |
| 6 | 202317088040-POWER OF AUTHORITY [22-12-2023(online)].pdf | 2023-12-22 |
| 7 | 202317088040-MARKED COPIES OF AMENDEMENTS [22-12-2023(online)].pdf | 2023-12-22 |
| 8 | 202317088040-FORM-26 [22-12-2023(online)].pdf | 2023-12-22 |
| 9 | 202317088040-FORM 18 [22-12-2023(online)].pdf | 2023-12-22 |
| 10 | 202317088040-FORM 13 [22-12-2023(online)].pdf | 2023-12-22 |
| 11 | 202317088040-FORM 1 [22-12-2023(online)].pdf | 2023-12-22 |
| 12 | 202317088040-FIGURE OF ABSTRACT [22-12-2023(online)].pdf | 2023-12-22 |
| 13 | 202317088040-DECLARATION OF INVENTORSHIP (FORM 5) [22-12-2023(online)].pdf | 2023-12-22 |
| 14 | 202317088040-COMPLETE SPECIFICATION [22-12-2023(online)].pdf | 2023-12-22 |
| 15 | 202317088040-AMMENDED DOCUMENTS [22-12-2023(online)].pdf | 2023-12-22 |
| 16 | 202317088040-Proof of Right [16-05-2024(online)].pdf | 2024-05-16 |
| 17 | 202317088040-FORM 3 [30-05-2024(online)].pdf | 2024-05-30 |